Kailera Therapeutics, Inc. (KLRA) Income Statement

59 Followers

Kailera Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Kailera Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q2, Kailera Therapeutics, Inc.'s net income was $-111.31M. See Kailera Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 158.34M
Depreciation and Amortization	$ 310.00K
EBITDA	$ -158.03M
Operating Income	$ -158.34M
Other Income/Expenses	$ 9.38M
Pretax Income	$ -148.96M
Net Income	$ -148.96M
Per Share Metrics
Basic EPS	$ -1.26
Diluted EPS	$ -1.26
Weighted Average Shares Outstanding	117.95M
Weighted Average Shares Outstanding (Diluted)	117.95M

Currency in USD

Kailera Therapeutics, Inc. (KLRA) Income Statement

Kailera Therapeutics, Inc. Income Statement

Kailera Therapeutics, Inc. Earnings and Revenue History